The Phase II trial conducted by the Maria Skłodowska-Curie National Research Institute of Oncology (MSCNRIO) in Warsaw, the national reference centre for STS in Poland, has reached its enrolment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback